This work is licensed under a Creative Commons Attribution 4.0 International License.
At4
General Information
DRACP ID DRACP04551
Peptide Name At4
Sequence KLLKKLLKLLKKLLK
Sequence Length 15
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Active ACP
Activity Information
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Acetylation
C-terminal Modification Amidation
Other Modification None
Chiral L
Physicochemical Information
Formula C90H174N22O16
Absent amino acids ACDEFGHIMNPQRSTVWY
Common amino acids L
Mass 207043
Pl 11.58
Basic residues 7
Acidic residues 0
Hydrophobic residues 8
Net charge 7
Boman Index 51
Hydrophobicity 20.67
Aliphatic Index 208
Half Life
Mammalian: 1.3 hour
Yeast: 3 min
E.coli: 2 min
Extinction Coefficient cystines 0
Absorbance 280nm 0
Polar residues 0
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 36174494
Title Anticancer effect of rationally designed δΌͺ-helical amphiphilic peptides
Doi Not available
Year 2022
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available
External Code
DBAASP ID 20548
This work is licensed under a Creative Commons Attribution 4.0 International License.